- Home
- VOC vs ANL Comparison
VOC vs ANL Comparison
Compare VOC & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOC
- ANL
- Stock Information
- Founded
- VOC 2010
- ANL 2004
- Country
- VOC United States
- ANL Cayman Islands
- Employees
- VOC N/A
- ANL N/A
- Industry
- VOC Oil & Gas Production
- ANL
- Sector
- VOC Energy
- ANL
- Exchange
- VOC Nasdaq
- ANL Nasdaq
- Market Cap
- VOC 48.6M
- ANL 56.0M
- IPO Year
- VOC 2011
- ANL 2023
- Fundamental
- Price
- VOC $2.93
- ANL $1.55
- Analyst Decision
- VOC
- ANL Hold
- Analyst Count
- VOC 0
- ANL 1
- Target Price
- VOC N/A
- ANL N/A
- AVG Volume (30 Days)
- VOC 66.2K
- ANL 7.4K
- Earning Date
- VOC 01-01-0001
- ANL 08-08-2025
- Dividend Yield
- VOC 21.30%
- ANL N/A
- EPS Growth
- VOC N/A
- ANL N/A
- EPS
- VOC 0.63
- ANL N/A
- Revenue
- VOC $11,917,424.00
- ANL N/A
- Revenue This Year
- VOC N/A
- ANL N/A
- Revenue Next Year
- VOC N/A
- ANL N/A
- P/E Ratio
- VOC $4.59
- ANL N/A
- Revenue Growth
- VOC N/A
- ANL N/A
- 52 Week Low
- VOC $2.44
- ANL $1.10
- 52 Week High
- VOC $5.69
- ANL $4.10
- Technical
- Relative Strength Index (RSI)
- VOC 53.46
- ANL 47.53
- Support Level
- VOC $2.82
- ANL $1.50
- Resistance Level
- VOC $2.93
- ANL $1.60
- Average True Range (ATR)
- VOC 0.10
- ANL 0.07
- MACD
- VOC 0.01
- ANL 0.02
- Stochastic Oscillator
- VOC 60.34
- ANL 60.42
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.